Pacific Biosciences (PACB) Files 5.5M Common Shelf for Shareholders
Tweet Send to a Friend
Up)
Pacific Biosciences (Nasdaq: PACB) filed a registration with the U.S. SEC to sell, from time to time, up to 5.5 million shares of its common stock upon the exercise of warrants plus an indeterminate number of shares of common stock that may be issued as a result of stock splits, stock dividends or similar transactions as described in the warrants.
Sales will be made on behalf of selling shareholders and Pacific Bio will not receive proceeds from the sales.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sales will be made on behalf of selling shareholders and Pacific Bio will not receive proceeds from the sales.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Pacific Biosciences and Sage Science Announce Co-Marketing Partnership
- Cyclacel Pharmaceuticals (CYCC) Announces Stock Offering
- Nielsen Holdings (NLSN) Prices 35M Shares at $35.01/Sh
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Dividend
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
